These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24502872)

  • 1. Association between labetalol use for hypertension in pregnancy and adverse infant outcomes.
    Xie RH; Guo Y; Krewski D; Mattison D; Walker MC; Nerenberg K; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():124-8. PubMed ID: 24502872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy.
    Xie RH; Guo Y; Krewski D; Mattison D; Walker MC; Nerenberg K; Wen SW
    BJOG; 2014 Aug; 121(9):1090-6. PubMed ID: 24628701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
    Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
    Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
    Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study.
    Pasker-de Jong PC; Zielhuis GA; van Gelder MM; Pellegrino A; Gabreëls FJ; Eskes TK
    BJOG; 2010 Aug; 117(9):1080-6. PubMed ID: 20477821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
    Dublin S; Idu A; Avalos LA; Cheetham TC; Easterling TR; Chen L; Holt VL; Nance N; Bider-Canfield Z; Neugebauer RS; Reynolds K; Badon SE; Shortreed SM
    PLoS One; 2022; 17(5):e0268284. PubMed ID: 35576217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1143-51. PubMed ID: 26265372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal side effects of maternal labetalol treatment in severe preeclampsia.
    Heida KY; Zeeman GG; Van Veen TR; Hulzebos CV
    Early Hum Dev; 2012 Jul; 88(7):503-7. PubMed ID: 22525036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].
    Plouin PF; Bréart G; Maillard F; Papiernik E; Relier JP
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):952-5. PubMed ID: 3116996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal haemodynamic effects following foetal exposure to labetalol in hypertensive disorders of pregnancy.
    Thewissen L; Pistorius L; Baerts W; Naulaers G; Van Bel F; Lemmers P
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1533-1538. PubMed ID: 27294851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal antihypertensive drugs may influence cerebral oxygen extraction in preterm infants during the first days after birth.
    Verhagen EA; Kooi EM; van den Berg PP; Bos AF
    J Matern Fetal Neonatal Med; 2013 Jun; 26(9):871-6. PubMed ID: 23330812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes.
    Orbach H; Matok I; Gorodischer R; Sheiner E; Daniel S; Wiznitzer A; Koren G; Levy A
    Am J Obstet Gynecol; 2013 Apr; 208(4):301.e1-6. PubMed ID: 23159698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?
    Magee LA; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort W; Welch R; Thornton JG; Moutquin JM;
    Hypertension; 2016 Nov; 68(5):1153-1159. PubMed ID: 27620393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension.
    Sanusi AA; Leach J; Boggess K; Dugoff L; Sibai B; Lawrence K; Hughes BL; Bell J; Aagaard K; Edwards RK; Gibson KS; Haas DM; Plante L; Metz TD; Casey B; Esplin S; Longo S; Hoffman MK; Saade GR; Hoppe KK; Foroutan J; Tuuli M; Owens MY; Simhan HN; Frey H; Rosen T; Palatnik A; Baker S; August P; Reddy UM; Su EJ; Krishna I; Nguyen NA; Norton ME; Skupski D; El-Sayed YY; Ogunyemi D; Galis ZS; Harper L; Ambalavanan N; Geller NL; Kuo HC; Sinkey RG; Librizzi R; Pereira L; Magann EF; Habli M; Williams S; Mari G; Pridjian G; McKenna DS; Parrish M; Chang E; Osmundson S; Quinones J; Szychowski JM; Tita ATN
    Obstet Gynecol; 2024 Jul; 144(1):126-134. PubMed ID: 38949541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial.
    Plouin PF; Breart G; Maillard F; Papiernik E; Relier JP
    Br J Obstet Gynaecol; 1988 Sep; 95(9):868-76. PubMed ID: 3056503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial.
    Rezk M; Emarh M; Masood A; Dawood R; El-Shamy E; Gamal A; Badr H
    Hypertens Pregnancy; 2020 Nov; 39(4):393-398. PubMed ID: 32697618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
    van de Vusse D; Mian P; Schoenmakers S; Flint RB; Visser W; Allegaert K; Versmissen J
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1763-1776. PubMed ID: 36104450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The occurrence of small for gestational age infants and perinatal and maternal outcomes in normal and poor maternal weight gain singleton pregnancies.
    Jariyapitaksakul C; Tannirandorn Y
    J Med Assoc Thai; 2013 Mar; 96(3):259-65. PubMed ID: 23539926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.